ARWR - Arrowhead Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$83.56
DETAILS
HIGH:
$110.00
LOW:
$35.00
MEDIAN:
$90.00
CONSENSUS:
$83.56
UPSIDE:
11.49%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,183,838 | $74.2M | 0.0% | +1,037,774 | INCREASED |
| Dalio | 95,552 | $6.0M | 0.0% | +35,586 | INCREASED |
| Greenblatt | 38,168 | $2.4M | 0.0% | -18,105 | DECREASED |
| Wood | 11,500 | $721,050 | 0.0% | +6,700 | INCREASED |
| Laffont | 3,797 | $238,072 | 0.0% | +3,797 | NEW |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-12 | Lu Hongbo | director | SELL | 2,970 | $76.88 | $228K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 3,208 | $70.11 | $225K |
| 2026-04-23 | Hamilton James C | officer: Chief Medical Officer | SELL | 10,000 | $75.00 | $750K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 1,157 | $70.45 | $82K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 8,730 | $71.92 | $628K |
| 2026-03-05 | Hamilton James C | officer: Chief Medical Officer | SELL | 10,000 | $64.19 | $642K |
| 2026-01-06 | Hamilton James C | officer: Chief Medical Officer | A-Award | 75,000 | -- | -- |
| 2026-01-06 | Apel Daniel Joseph | officer: Chief Financial Officer | A-Award | 75,000 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | A-Award | 75,000 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | G-Gift | 540 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | G-Gift | 440 | -- | -- |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 13,451 | $62.96 | $847K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 313 | $68.00 | $21K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 600 | $61.12 | $37K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 900 | $62.25 | $56K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 2,336 | $64.04 | $150K |
| 2026-01-05 | Hamilton James C | officer: Chief Medical Officer | SELL | 437 | $65.97 | $29K |
| 2026-01-02 | Anzalone Christopher Richard | director, officer: Chief Executive Officer | SELL | 7,416 | $65.88 | $489K |
| 2026-01-02 | Anzalone Christopher Richard | director, officer: Chief Executive Officer | SELL | 5,771 | $66.39 | $383K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 5,873 | $62.91 | $369K |
| 2026-01-05 | Hamilton James C | officer: Chief Medical Officer | SELL | 309 | $68.00 | $21K |
| 2025-12-31 | O'Brien Patrick | officer: COO | G-Gift | 560 | -- | -- |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 11,842 | $63.84 | $756K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 2,700 | $64.44 | $174K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 46 | $68.00 | $3K |